Lacto-N-fucopentaose I and 2'-Fucosyllactose (‘LNFP-I and 2'-FL’) mixture (produced using a derivative strain of E. coli K-12 DH1): authorised novel food in the EU
Lacto-N-fucopentaose I and 2'-Fucosyllactose (‘LNFP-I and 2'-FL’) mixture (produced using a derivative... is on the Union list of authorised novel foods (Implementing Regulation (EU) 2017/2470). Conditions of use and maximum levels by food category: 17 entries, quoted below.
- Regulation
- Implementing Regulation (EU) 2017/2470, Annex, Table 1
- Listed as
- Lacto-N-fucopentaose I and 2'-Fucosyllactose (‘LNFP-I and 2'-FL’) mixture (produced using a derivative strain of E. coli K-12 DH1)
- Text version
- Consolidated text of 10 August 2026
- Version
- Consolidated text of 10 August 2026
- Official source
- Implementing Regulation (EU) 2017/2470, Annex, Union list of novel foods
Conditions of use and maximum levels
Table 1, column "Conditions under which the novel food may be used", as written:
- Infant formula as defined under Regulation (EU) No 609/2013: 2,0 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
- Follow-on formula as defined under Regulation (EU) No 609/2013: 2,0 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
- Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products: 1,5 g/L
- Unflavoured fermented milk-based products: 1,5 g/L (beverages)
- Unflavoured fermented milk-based products: 3,0 g/kg (products other than beverages)
- Flavoured fermented milk-based products including heat-treated products: 1,5 g/L (beverages)
- Flavoured fermented milk-based products including heat-treated products: 15,0 g/kg (products other than beverages)
- Milk based drinks and similar products: 1,5 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
- Food for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013: In accordance with the particular nutritional requirements of the persons for whom the products are intended but in any case not higher than the maximum levels specified for the proposed food categories or higher than 2,0 g/L or 2,0 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
- Food for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children: In accordance with the particular nutritional requirements of the persons for whom the products are intended but in any case not higher than the maximum levels specified for the proposed food categories or higher than 4,5 g/day in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
- Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013: 3,0 g/L (beverages)
- Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013: 4,5 g/kg (products other than beverages)
- Beverages (flavoured drinks, excluding drinks with a pH less than 5): 1,5 g/kg
- Cereal bars: 15,0 g/kg
- Processed cereal-based food and baby food for infants and young children as defined in Regulation (EU) No 609/2013: 1,5 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
- Processed cereal-based food and baby food for infants and young children as defined in Regulation (EU) No 609/2013: 9,1 g/kg for products other than beverages
- Food supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children: 4,5 g/day
Additional specific labelling requirements
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lacto-N-fucopentaose I and 2'-Fucosyllactose mixture’. The labelling of food supplements containing Lacto-N-fucopentaose I and 2'-Fucosyllactose (‘LNFP-I and 2'-FL’) mixture produced by a derivative strain of E. coli K-12 DH1 shall bear a statement that: (a) they should not be consumed by children under 3 years of age; (b) they should not be used, if other foods containing added Lacto-N-fucopentaose I and 2'-Fucosyllactose mixture and/or foods containing added 2'-Fucosyllactose are consumed on the same day.
Specification (Table 2)
Table 2 of the Annex, row with the same name, as written:
Description:
Lacto-N-fucopentaose I and 2'-Fucosyllactose mixture is a purified and concentrated white to off-white powder produced using genetically modified strain of Escherichia coli K-12 DH1.
Definition:
Lacto-N-fucopentaose I
Chemical name: α-L-Fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→3)-2-(acetylamino)-2- deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranose
Chemical formula: C32H55NO25
Molecular mass: 853,77 Da
CAS No: 7578-25-8
2'-Fucosyllactose
Chemical name: α-L-Fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-D-glucopyranose
Chemical formula: C18H32O15
Molecular mass: 488,44 Da
CAS No: 41263-94-9
Characteristics/Composition:
Lacto-N-fucopentaose I and 2'-Fucosyllactose mixture (% w/w of dry matter): ≥ 75,0
Lacto-N-fucopentaose I (% w/w of dry matter): 50,0 - 75,0
2'-Fucosyllactose (% w/w of dry matter): 15,0 - 35,0
Lacto-N-Tetraose (% w/w): ≤ 5,0
3-Fucosyllactose (% w/w): ≤ 1,0
D-Lactose (% w/w): ≤ 10,0
Difucosyllactose (% w/w): ≤ 2,0
Lacto-N-fucopentaose I fructose isomer (% w/w): ≤ 1,5
2'-Fucosyl-D-lactulose (% w/w): ≤ 1,0
Sum of L-Fucose and 2′-Fucosyl-D-lactitola (% w/w): ≤ 1,0
Sum of Lacto-N-fucopentaose I, 2'-Fucosyllactose, Lacto-N-Tetraose, Difucosyllactose, 3-Fucosyllactose, D-Lactose, L-Fucose, 2′-Fucosyl-D-lactitol, Lacto-N-fucopentaose I fructose isomer, and 2'-Fucosyl-D-lactulose (% w/w dry matter): ≥ 90,0
Sum of other carbohydrates (% w/w): ≤ 6,0
Moisture (% w/w): ≤ 8,0
pH (20 °C, 5 % solution): 4,0 -7,0
Ash (% w/w): ≤ 0,5
Residual protein (% w/w): ≤ 0,01
Heavy metals and contaminants:
Arsenic: ≤ 0,2 mg/kg
Cadmium: ≤ 0,1 mg/kg
Lead: ≤ 0,02 mg/kg
Mercury: ≤ 0,1 mg/kg
Aflatoxin M1: ≤ 0,025 μg/kg
Microbiological criteria:
Total plate count: ≤ 1 000 CFU/g
Enterobacteriaceae: Absence in 10 g
Salmonella spp.: Absence in 25 g
Yeasts and moulds: ≤ 100 CFU/g
Cronobacter spp.: Absence in 10 g
Listeria monocytogenes: Absence in 25 g
Presumptive Bacillus cereus: ≤ 50 CFU/g
Endotoxins: ≤ 10 EU/mg
a L-Fucose and 2′-Fucosyl-D-lactitol peaks on the High Performance Anion Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD) chromatogram overlap.
CFU: Colony Forming Units; EU: Endotoxin Units
Source and version
Implementing Regulation (EU) 2017/2470, Annex, Union list of novel foods, Table 1. Consolidated text of 10 August 2026. The text above is copied from that document without change except that amendment markers are removed. It is not advice and it does not decide whether a particular product is covered.
Want the whole list as one table?
If we publish the Union list as one table (name, food category, maximum level), we write to you once. We use the email for nothing else.